André Willasch

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group

Peter Bader, Hermann Kreyenberg, Günter Henze et al. · Journal of Clinical Oncology · 2008 · 358 citations · Full text

Medicine, Oncology, Pediatrics +14

Ketoacidosis at onset of type 1 diabetes mellitus in children - frequency and clinical presentation

Andreas Neu, André Willasch, Stefan Ehehalt et al. · Pediatric Diabetes · 2003 · 153 citations

Medicine, Endocrinology, Pediatrics +8

Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial

Peter Bader, Hermann Kreyenberg, Arend von Stackelberg et al. · Journal of Clinical Oncology · 2015 · 131 citations

Medicine, Hematology, Oncology +16

Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia

Iris H.I.M. Hollink, Marry M. van den Heuvel‐Eibrink, Martin Zimmermann et al. · Blood · 2009 · 131 citations · Full text

Medicine, Genetics, Oncology +17

Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation

Eva Rettinger, André Willasch, Hermann Kreyenberg et al. · Blood · 2011 · 107 citations

Medicine, Hematology, Oncology +17